Latest News

Thermon Group Holdings (THR) is back on investors’ radar after third quarter results showed higher sales, steady profitability, and stronger year to date figures, along with commentary pointing to opportunities in electrification and infrastructure spending. See our latest analysis for Thermon Group Holdings. Those third quarter results, together with plans for acquisitions funded by US$141 million of available liquidity and a completed share buyback, sit alongside a strong recent run, with a...

Plug Power (PLUG) is in the spotlight after a new securities class action lawsuit, leadership changes, and an upcoming shareholder vote converge with its Project Quantum Leap cost saving and profitability plan. See our latest analysis for Plug Power. The recent class action filings, leadership change and upcoming charter vote come after a tough stretch for the share price, with a 90 day share price return of 25.27% decline but a 1 year total shareholder return of 25.93% gain. This suggests...

Why Aris Mining Just Hit Momentum Screens Aris Mining (TSX:ARIS) has drawn fresh attention after being added to the Minervini Growth and Momentum Screen, a move that highlights its mix of strong technical action and fundamental progress. See our latest analysis for Aris Mining. That momentum screen inclusion comes after a strong run, with the share price at CA$26.35, backed by a 90 day share price return of 66.14% and a very large 1 year total shareholder return that reflects shifting...

Under Armour, Inc. reported past third-quarter 2025 results showing sales of US$1,327.76 million versus US$1,401.04 million a year earlier, and a net loss of US$430.83 million compared with prior net income of US$1.23 million, while also guiding to a full-year revenue decline and deeper operating loss amid tariff and demand pressures. Despite weaker revenues and elevated losses, management raised its full-year profit outlook and highlighted early benefits from its operating model overhaul,...

Parker-Hannifin recently reported second-quarter fiscal 2026 results showing higher sales of US$5,174 million compared to a year earlier, alongside slightly lower net income of US$845 million, and simultaneously completed a long-running share repurchase program totaling 30,913,829 shares for about US$6.43 billion. The company also raised its full-year fiscal 2026 outlook for sales growth, segment operating margins, and both reported and adjusted EPS, signaling increased management confidence...

Mitsui & Co., Ltd. reported nine‑month results to December 31, 2025, with sales of ¥10,356,267 million and net income of ¥611,950 million, and issued full‑year 2026 profit guidance of ¥820,000 million, or ¥286.26 per basic share. At the same time, renewed attention on Warren Buffett’s sizeable Berkshire Hathaway stake in Japan’s trading houses has drawn fresh focus to Mitsui’s role in this group. Next, we’ll examine how Mitsui’s new profit guidance and Buffett‑linked investor interest may...

Estée Lauder has filed a federal lawsuit against Walmart, alleging that counterfeit Estée Lauder products were sold on Walmart's third party online marketplace. The case centers on claims that some beauty products offered through Walmart's platform were not authentic Estée Lauder items. The lawsuit puts a spotlight on Walmart's marketplace controls for brand protection, product sourcing, and seller oversight. For investors watching NasdaqGS:WMT, this case touches a key part of Walmart's...

As February 2026 begins, the U.S. stock market has seen a robust start with major indices like the Dow Jones Industrial Average and S&P 500 showing significant gains, reflecting positive investor sentiment despite recent economic uncertainties such as government shutdowns and changes in Federal Reserve leadership. In this dynamic environment, identifying high-growth tech stocks requires careful consideration of factors such as innovation potential, adaptability to market shifts, and financial...

As the U.S. stock market kicks off February with significant gains, highlighted by the Dow Jones Industrial Average's 515-point surge and the S&P 500 nearing a record high, investors are keenly observing opportunities amid this bullish sentiment. In such an environment, identifying stocks that may be trading below their fair value can present potential investment opportunities, particularly when considering companies like Autodesk and others that might offer strong fundamentals at attractive...

As February 2026 begins, U.S. stock markets have shown strong momentum with major indexes like the Dow and S&P 500 ending sharply higher, reflecting investor optimism amid recent economic developments such as trade deals and manufacturing growth. In this buoyant market environment, companies with high insider ownership often attract attention as their leadership's vested interest can signal confidence in long-term growth potential.

As February begins, major U.S. stock indexes have shown a strong start, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. In this context of market optimism, investors may find interest in exploring penny stocks—an investment area that often involves smaller or newer companies. Although the term "penny stocks" might seem outdated, these investments can still offer surprising value and potential for growth when backed by solid financial health.

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones and S&P 500 showing significant gains, reflecting a positive investor sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this vibrant yet complex environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and growth potential amidst evolving economic conditions.

As February 2026 begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this dynamic market environment, dividend stocks can offer investors a blend of income and potential growth, making them an attractive consideration amidst ongoing economic developments.

Moody’s recently came under pressure after weaker earnings guidance from industry peer S&P Global raised concerns about conditions facing credit rating and financial data providers. The episode highlights how sentiment toward one major ratings and data firm can quickly influence expectations for others ahead of their own results. We’ll now examine how these sector-wide worries about earnings sustainability could affect Moody’s investment narrative built around private credit and...

Institutional exit reshapes the register Regal Partners and its associates have exited their substantial holding in Dalrymple Bay Infrastructure (ASX:DBI). This move reshapes the company’s institutional investor mix and could influence how its shares trade in the near term. See our latest analysis for Dalrymple Bay Infrastructure. At A$5.09, Dalrymple Bay Infrastructure’s recent 17.55% 90 day share price return sits alongside a 47.44% 1 year total shareholder return and a very large 5 year...

In early February 2026, Bruker, through its Chemspeed Technologies and SciY divisions, introduced an open Self-Driving Lab platform and launched the iNTApharma nanoscale bioparticle characterization system at SLAS2026, while also declaring a quarterly cash dividend of US$3.9844 per share on its 6.375% Mandatory Convertible Preferred Stock. By combining autonomous, AI-orchestrated lab workflows with label-free, native-state nanoparticle analysis, Bruker is targeting bottlenecks in advanced...

In February 2026, Humacyte, Inc. reported that the U.S. Department of Defense’s Fiscal Year 2026 Appropriations Act includes dedicated funding to evaluate and incorporate biologic vascular repair technologies, directly aligning with its FDA-approved human-derived bioengineered blood vessel Symvess for traumatic extremity vascular injuries in service members. This federal support highlights growing institutional recognition of bioengineered human vessels as an off-the-shelf option when...

In late January and early February 2026, Canadian National Railway reported higher fourth-quarter and full-year 2025 earnings, raised its 2026 dividend by 3%, completed a CAD 2,177.6 million buyback of 16,000,000 shares, and authorized a new program to repurchase up to 24,000,000 additional shares by February 2027. This combination of rising earnings, a higher dividend, and continued share repurchases highlights management’s confidence in the company’s cash generation and its commitment to...

Keysight Technologies (NYSE: KEYS) has launched its SOS Enterprise platform, focused on AI readiness and compliance in engineering data management. The platform is designed to organize engineering data, automate compliance tasks, and support secure AI integration for sectors such as aerospace and automotive. Keysight Technologies, trading at $235.0, is drawing attention from investors as it connects its test and measurement expertise with data centric software such as SOS Enterprise. The...

Globus Medical stock in focus after recent price moves Globus Medical (GMED) is back on investor radars after recent trading left the share price around $88.72, with returns mixed over the past month and the past 3 months. See our latest analysis for Globus Medical. The recent 1 day share price return of 1.29% sits against a softer 30 day share price return of 6.09% and a year to date share price return of 1.63%. The 1 year total shareholder return of 5.27% and 3 year total shareholder return...

Evommune (EVMN) is back in focus after reporting statistically significant positive top-line results from its Phase 2a EVO301 trial in moderate to severe atopic dermatitis, including clear separation from placebo and a favorable safety readout. See our latest analysis for Evommune. The positive EVO301 data has coincided with a sharp re-rating in the stock, with a 1-day share price return of 70.87% and a year-to-date share price return of 67.71% off a last close of $29.03. This indicates...

Toenec (TSE:1946) is back on investors’ radar after reporting nine month results to December 31, 2025, together with fresh full year guidance that points to higher operating and attributable profit expectations. See our latest analysis for Toenec. The latest guidance and nine month results seem to have shifted sentiment, with the share price at ¥2,191 and recent momentum strong, including a 30 day share price return of 9.5% and a 1 year total shareholder return of 130.56%, on top of a very...

Why this earnings report matters for IES Holdings (IESC) IES Holdings (IESC) just posted first quarter results that put fresh numbers around the company’s current momentum, with higher sales, higher net income and higher earnings per share compared with the same period a year ago. See our latest analysis for IES Holdings. The strong first quarter update comes on top of an intense share price run, with an 18.82% 7-day share price return, 28.40% 90-day share price return and very large...

Citizens Financial Group recently presented at the KBW 2026 Winter Financial Services Conference in Boca Raton, outlining its latest banking initiatives and market priorities. The bank’s push into new geographies, greater use of AI, and expanded private banking and capital markets capabilities marks a meaningful shift in how it aims to grow and manage risk. We’ll now explore how Citizens’ nationwide expansion and AI-driven efficiency push could reshape its existing investment narrative for...